Terrance P. Coyne, EVP & CFO at Royalty Pharma plc (RPRX), sold 34,791 shares at $49.78 ($1.7M) on 2026-04-28, disclosed to the SEC on 2026-04-30.
Scheduled sale ($1.7M) by EVP & CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.78 | 1,875 | $93K | 5.4% |
| 2 | $49.78 | 32,916 | $1.6M | 94.6% |
| Total | $49.78 avg | 34,791 | $1.7M | 100% |
| Filing → |
| RPRX | SELL | 2026-04-02 | $1.7M | — | Filing → |
| RPRX | SELL | 2026-03-25 | $3.2M | — | Filing → |
| RPRX | SELL | 2026-03-04 | $3.3M | — | Filing → |